Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Helix Biopharma Corp. (HBPCF) had Weighted-Average Shares Outstanding (Diluted) of 76.38M for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-0.49M |
|
-- |
|
-- |
|
$0.50M |
|
$-0.50M |
|
$0.01M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.50M |
|
$-0.50M |
|
76.38M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
76.38M |
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.18M |
|
$0.00M |
|
$13.41M |
|
$15.59M |
|
$4.88M |
|
-- |
|
-- |
|
$4.88M |
|
$10.71M |
|
$-2.70M |
|
$10.71M |
|
76.38M |
|
| Cash Flow Statement Financials | |
$-1.86M |
|
-- |
|
$3.88M |
|
$0.05M |
|
$2.06M |
|
$2.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.45 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.57% |
|
18.14% |
|
-3.14% |
|
-4.57% |
|
$0.14 |
|
$-0.02 |
|
$-0.02 |
|